Expert Pitch
Saint Joseph's University

Saint Joseph's University Bioethicist Available to Discuss Ethics of Care Rationing

21-Apr-2020 11:30 AM EDT, by Saint Joseph's University

As the nation faces a rising number of patients diagnosed with COVID-19, it’s become increasingly evident that one concern may outweigh all others — there may not be enough ventilators and life-saving drugs to supply everyone in need with them.

The team at the Institute of Clinical Bioethics at Saint Joseph's University, including Peter Clark, S.J., Ph.D. ‘75, professor of medical ethics and director of the ICB have been working closely with the institute’s 17 affiliated hospitals to address broader ethical issues that have come up due to the spread of COVID-19. 

According to Clark, each provider is charged with developing its own protocols and procedures for care, but also must take into consideration any policies being developed by individual states.

“The problem is that the health systems are coming up with policies on allocations of services, but so is the state,” says Clark. “We have to adhere to the state guidelines, but those guidelines can only be looked at if the states’ governors activate them,” which has not yet been the case in the three states where ICB-affiliated providers are located. 

At each hospital, triage teams have been tasked with making the tough decisions about rationing care, should the need arise. The teams consist of one critical care physician, one critical care nurse and one respiratory therapist. By moving the decision from the bedside physician to the triage team, the burden — and pressure — is lifted from the doctors dealing directly with patients, Clark says.

“Triage is based on a very clinical, complex scoring system called a SOFA score — Sequential Organ Failure Assessment,” says Clark. “These scores are based purely on symptoms and comorbidities [the presence of other conditions in addition to the patient’s primary condition], all in an attempt to make these decisions as objective as possible across the board.”

Transparency in the triage process is essential in ensuring that all members of the community know exactly what standards are being put into place, Clark says. 

“As Catholic teachings tell us, each human life has inherently equal moral worth,” says Clark. “These systems and protocols help us to ensure that decisions are made based upon that ideology.” 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.50519